B01 VENETOCLAX TARGETED THERAPY in AL AMYLOIDOSIS PATIENTS: A RETROSPECTIVE ANALYSIS FROM THE FRENCH AMYLOIDOSIS NETWORKMurielle Roussel, Arnaud Jaccard, Oscar Rizzo et al.|HemaSphere|2023Cited by 5
Venetoclax-Targeted Therapy in t(11;14) AL Amyloidosis Patients after Frontline Daratumumab and Cybord: A Retrospective Analysis from the French Amyloidosis NetworkMurielle Roussel, Arnaud Jaccard, Michelle Pirotte et al.|Blood|2022Cited by 3